6.36
+1.62(+34.18%)
Currency In USD
| Previous Close | 4.74 |
| Open | 5.43 |
| Day High | 6.7 |
| Day Low | 5.32 |
| 52-Week High | 15.1 |
| 52-Week Low | 4.02 |
| Volume | 4.59M |
| Average Volume | 1.24M |
| Market Cap | 345.58M |
| PE | -1.77 |
| EPS | -3.6 |
| Moving Average 50 Days | 5.32 |
| Moving Average 200 Days | 8.28 |
| Change | 1.62 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $204.44 as of May 09, 2025 at a share price of $6.36. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $75.22 as of May 09, 2025 at a share price of $6.36.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
GlobeNewswire Inc.
May 01, 2025 9:07 PM GMT
Agreement will facilitate widespread distribution of NARCAN® Nasal Spray throughout OntarioWINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of a
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire Inc.
Apr 22, 2025 12:00 PM GMT
GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025. Participants
Emergent BioSolutions Announces Stock Repurchase Program
GlobeNewswire Inc.
Mar 31, 2025 12:00 PM GMT
GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company’s common stock on or before March 27, 2026. “